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New Understanding of Algae
Within one week, British botanist Brian A.
Whitton received two phone calls about
cyanobacteria in local reservoirs-one caller
wanted to know how to eradicate a poten-
tially toxic bloom, the other wanted advice
on marketing a related species as a health
food. The anecdote, shared by Whitton at
the 4th International Conference on Toxic
Cyanobacteria, held 27 September-1
October 1998 at the Duke University
Marine Laboratory in Beaufort, North
Carolina, points to the complexities in
understanding such organisms; some con-
tain potent toxins and others promise
health and therapeutic benefits.
An unprecedented number of labora-
tories worldwide are studying cyanobacte-
ria, also known as blue-green algae, and
participation at the September conference
ballooned from early predictions, said
conference cochair Wayne Carmichael, a
cyanobacteria researcher and professor of
aquatic biology and toxicology at Wright
State University in Dayton, Ohio.
Microcystins were a common theme
among many presentations. Toxic sub-
stances manufactured in the cells of some
cyanobacteria, microcystins have been
blamed for the liver failure and subsequent
death of 75 dialysis patients at a clinic in
Caruaru, Brazil, in 1996, said Carmichael.
Other patients suffered nausea, vomiting,
headache, and visual disruption, including
blindness. The poisonings occurred in
spite of water treatment methods in place
that should have removed the contami-
nants from the clinic's water supply.
Although microcystins have also been sus-
pected in dialysis clinic deaths in Portugal,
the Brazil fatalities were the only ones to
date documented by analyses of blood
serum and tissue samples.
Could this scenario occur in the
United States or other developed nations?
Cyanobacteria appear around the world in
freshwater lakes and brackish waterways;
some even tolerate seawater, and a few are
terrestrial. Aquatic blooms flourish in the
presence of increased nutrients, especially
phosphorus. Carmichael reminded confer-
ence participants that water treatment pro-
cedures are only as good as the upkeep that
accompanies them.
"We tend to pride ourselves on the fact
that we have better water treatment [in the
developed world]," he said. "But if you
look at the water treatment process in
place here, it's not much different than any
other place in the world. I'm told that in
most dialysis clinics in the United States,
it's not a fail-safe procedure, that it needs
to be maintained properly."
In a study of selected water utilities
throughout the United States and Canada
during 1996 and 1997, Carmichael and his
colleagues found microcystins in 65% of
water samples that had not undergone treat-
ment. A third of the positive samples regis-
tered levels of microcystins in excess of the
recently adopted World Health
Organization (WHO) drinking water stan-
dard of 1.0 jig/1 of total microcystin. In a
few cases, treated water samples contained
microcystin levels higher
than the MHO guideline.
Cyanobacteria
species number in the
thousands, and it is not
known what percentage
produce toxins. Besides
microcystins, which
attack the liver, other
cyanotoxins have been
identified that affect the
nervous system and
cause skin rashes. For
more than a century,
blue-green algae have been implicated in
the deaths of livestock and other animals
that drink contaminated water. People
have historically avoided drinking from
and bathing in lakes and other waters
laden with surface scum, primarily because
the algae produce a bad taste and odor.
"Decreasing water quality throughout
the world means that these blooms are pre-
sent more often and for a longer duration,
and people are using marginal water sup-
plies more than they did in the past. They
are forced to bathe in a bloom or to use
water from a bloom," says Carmichael.
"We are now starting to see acute poison-
ings, contact irritations, accidental inges-
tion, and low-dose exposure [that may
result in] liver cancer."
Ian Falconer, a professor at the
University ofAdelaide Medical School in
Australia, said reports of contaminated
drinking water are pushing blue-green
algae into the spotlight. "Lead, arsenic, and
things like that are known environmental
contaminants," Falconer said, "where
cyanobacteria have only really become sig-
nificant through eutrophication. There is
an issue everywhere with respect to the
water industry in meeting the WHO
guidelines. The other issue is whether the
most sophisticated treatments, which are
more expensive, are actually [being used]."
Scientists from 35 countries made up
the more than 150 participants at the con-
ference, and presented on a range oftopics
including laboratory toxicity and develop-
mental tests in animals, molecular analysis,
toxin detection, regulation, and ecological
studies. The beneficial aspects ofcyanobac-
teriawere also represented. Whilesuch algae
as Microcystis, Anabaena, and Nodularia
produce chemicals lethal to humans and
animals, some blue-green algae produce
compounds that have anticarcinogenic,
antibacterial, or antifungal properties.
Extracts ofa blue-green algae have pro-
duced the antitumor drug cryptophycin,
which is currently in clinical trials, said
Richard Moore, a professor ofchemistry at
the University of Hawaii in Honolulu.
Blue-green bombshell. Cyanobacteria such as Microcystis aeruginosa (I)
and Nodularia (r) contaminate much ofthe world's watersupplywith tox-
insthatcause serious health effects.
Extracts from a marine blue-green algae
collected in Guam have also exhibited anti-
tumor properties, and appear to be chemi-
cally similar to dolastatin 10, a compound
derived from marine mollusks that is also
undergoing clinical trials as a cancer drug,
Moore said.
Consumption of blue-green algae has
also been touted as a health benefit by the
dietary supplement industry. More than 1
million people in the United States and
Canada consume blue-green algae in cap-
sule or tablet form. Much ofthe product is
harvested from blooms ofAphanizomenon
in Oregon's Klamath Lake. Concurrent
toxic blooms of Microcystis aeruginosa in
1996 prompted consumer concern about
the safety of the product. Health officials
subsequently determined a standard of 1
pg/g (equal to 1 ppm) to be a safe level of
microcystins in supplements, said Duncan
Gilroy, a public health toxicologist with
the Oregon Health Division in Portland.
But 50 of 67 samples obtained from har-
vesters, wholesalers, and retail outlets
exceeded 1 ppm, he said. "We are con-
cerned about people getting exposure to
even low levels ofmicrocystin for the long
term," said Gilroy.
Alzheimer's Disease: A Basis
in Bacteria?
According to a study published in the June
1998 issue of Medical Microbiology and
Immunology, the bacterium Chlamydia
pneumoniaemay be linked with, or possibly
even responsible for, Alzheimer's disease, a
form of dementia that currently affects
approximately 4 million U.S. citizens.
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